Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
06:51am, Sunday, 11'th Feb 2024
The health sector has two things to offer: new ideas and consistent returns. As a result, healthcare stocks will continue to be a good choice for investors looking for growth opportunities in 2024.
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why
07:01pm, Friday, 09'th Feb 2024
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $70.01, moving +1.71% from the previous trading session.
Got $100? 2 Top Cathie Wood Stocks to Buy and Hold.
02:35pm, Sunday, 04'th Feb 2024
CRISPR Therapeutics recently reached a major milestone: the approval of its first product. Teladoc Health is taking steps to optimize efficiency and travel the path to profitability.
CRISPR Therapeutics AG (CRSP) Rises But Trails Market: What Investors Should Know
07:01pm, Friday, 02'nd Feb 2024
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $64.75, denoting a +0.12% change from the preceding trading day.
Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements
09:10pm, Thursday, 01'st Feb 2024
Healthcare stocks are one part of the stock market that has a lot of room to grow until 2024. The healthcare industry is growing because of the growing focus on health and well-being around the world
Is CRISPR Therapeutics a Buy in the New Bull Market?
05:02am, Tuesday, 30'th Jan 2024
CRISPR Therapeutics recently won approval for its first product, a potential blockbuster. The company expects to report clinical trial data from its immuno-oncology program this year.
These 5 growth stocks are now in buy ranges
08:01am, Thursday, 25'th Jan 2024
With the recent uptrend in large-cap stocks, as reflected by the performance of the SPDR S&P 500 ETF Trust NYSEARCA: SPY, many stocks with top revenue and earnings growth rates are flashing bullish te
Where Will CRISPR Therapeutics Be in 5 Years?
09:45am, Wednesday, 24'th Jan 2024
CRISPR Therapeutics' leading candidate recently received regulatory approval. This gene-editing therapy stands to improve the biotech's financial results.
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
09:30am, Tuesday, 23'rd Jan 2024
CRISPR Therapeutics just had its biggest collaborator pull out of a joint program. At the same time, management is cruising for business development opportunities.
2 gene editing stocks to keep on your 2024 watchlist
08:23am, Tuesday, 23'rd Jan 2024
Gene therapy will get its share of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. NASDAQ: VRTX and CRISPR Therapeutics AG NASDAQ: CRSP CR
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
05:05am, Monday, 22'nd Jan 2024
CRISPR Therapeutics reached three milestones in recent times and is on its way to product revenue. The biotech company is also making progress with other pipeline programs based on its cutting-edge ge
Could Editas Medicine Become the Next CRISPR Therapeutics?
09:37am, Sunday, 21'st Jan 2024
Editas Medicine is a gene-editing biotech, just like CRISPR Therapeutics. Editas has a long way to go before it'll be self-sustaining, and it might not get there.
Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics
08:00am, Sunday, 21'st Jan 2024
Intellia Therapeutics is well capitalized, and moving into late-stage clinical trials. CRISPR Therapeutics will be raking in revenue and likely launching another therapy.
3 High-Flying Stocks That Could Soar Even More in 2024
06:50am, Saturday, 20'th Jan 2024
CRISPR Therapeutics stock has room to run higher with the biotech's first therapy on the market. Eli Lilly is now the world's biggest drugmaker and has multiple growth drivers.
3 Under-the-Radar Tech Stocks With 250% Growth Potential by 2026
08:36am, Friday, 19'th Jan 2024
In the tech space, certain tech stocks stand as front-liners of innovation and strategic brilliance. This article delves into the riveting strategies of three companies that have not merely weathered
